Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
European Neurology|January 1, 1997
Freezing gait in Parkinson's diseaseP Lamberti, S Armenise, V Castaldo, et al.Journal of Biotechnology|June 27, 2000
Isinglass/collagen: denaturation and functionalityD Hickman, T J Sims, C A Miles, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Natural history and clinical features of progressive supranuclear palsy: a clinical studyC Diroma, C Dell'Aquila, A Fraddosio, et al.Italian Journal of Neurological Sciences|January 1, 1993
Neuro-Behçet: clinical features and MRI correlatesF Federico, M G Damiani, R De Blasi, et al.Functional Neurology|March 1, 1995
Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystoniaL Margari, M de Mari, P Lamberti, et al.European Journal of Neurology|April 5, 2005
Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administrationP Lamberti, S Zoccolella, E Armenise, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1996
Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosisP Maggi, M de Mari, R De Blasi, et al.Italian Journal of Neurological Sciences|November 7, 1999
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromesF Federico, I L Simone, V Lucivero, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1997
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsyF Federico, I L Simone, V Lucivero, et al.Parkinsonism & Related Disorders|March 1, 2005
Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medicationsS Zoccolella, P Lamberti, E Armenise, et al.Pageof 4